Actelion Must Face Tracleer Antitrust Suit With Class Certified
By Bryan Koenig · September 6, 2024, 9:57 PM EDT
A Maryland federal judge refused Friday to toss an antitrust suit accusing Actelion Pharmaceuticals of illegally denying generics companies the samples they needed to produce generic versions of its hypertension drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login